NCT06539429View on ClinicalTrials.gov

Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

October 22, 2024

Primary Completion Date

May 15, 2026

Study Completion Date

May 15, 2026

Conditions

Osteoarthritis, Knee

Interventions

BIOLOGICAL

ANT-301

Administration on Day 1

Trial Locations (1)

03080

Seoul National University, Seoul

All Listed Sponsors

lead

Anterogen Co., Ltd.

INDUSTRY